Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

24 janv. 2019 08h43 HE | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: CORRECTION: MANDATORY NOTIFICATION OF TRADE, PRIMARY INSIDER IN HOFSETH BIOCARE ASA

Hofseth AS, a 100 % owned company of Hofseth International AS (partly, indirectly owned by CEO Roger Hofseth and Chairman of the Board Ola Holen), has today received 157,687 shares in Hofseth BioCare...
24 janv. 2019 08h15 HE | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE, PRIMARY INSIDER IN HOFSETH BIOCARE ASA

Hofseth AS, a 100 % owned company of Hofseth International AS (partly, indirectly owned by CEO Roger Hofseth and Chairman of the Board Ola Holen), has today received 185,714 shares in Hofseth BioCare...
10 déc. 2018 05h52 HE | Source: Hofseth Biocare ASA

Hofseth BioCare ASA: NEW STUDY SHOWS CALGO® IS SUPERIOR TO TRADITIONAL CALCIUM SOURCES ON OSTEOBLAST AND CALCIUM DEPOSITION

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hofseth BioCare ASA (HBC) produces CalGo®,...
02 nov. 2018 03h02 HE | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: HBC Third Quarter 2018 Financial Report

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hofseth BioCare had operating revenues of NOK...
26 sept. 2018 05h31 HE | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: REGISTRATION OF SHARE CAPITAL INCREASE

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Reference is made to the stock exchange notice...
11 sept. 2018 08h36 HE | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: Result of the subsequent offering

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Reference is made to the stock exchange...
10 sept. 2018 02h15 HE | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: LAST DAY OF SUBSCRIPTION PERIOD

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Reference is made to the stock exchange notice...
06 sept. 2018 03h05 HE | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: New study and US provisional patent filed on regulation of oxidative protective genes in human cells with ProGo for treatment of IBD, such as ulcerative colitis and Crohn's

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} An invitro study on the regulation of...
27 août 2018 10h17 HE | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: HBC Second Quarter 2018 Financial Report

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hofseth BioCare ASA had operating revenues of...
24 août 2018 01h50 HE | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: PUBLICATION OF PROSPECTUS - FURTHER INFORMATION ABOUT THE SUBSEQUENT OFFERING

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Reference is made to the stock exchange...

Page précédente

Page suivante